Online citations, reference lists, and bibliographies.
← Back to Search

How Ageing Processes Influence Cancer

J. P. Magalhães
Published 2013 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The ageing of populations worldwide is leading to an unprecedented increase in cancer cases and fatalities. Understanding the links between cancer and ageing is therefore more important than ever. How the interplay of ageing-associated changes affects cancer initiation and progression is complex, however, and some ageing processes probably foster cancer development whereas others hinder it, possibly in a tissue-specific manner. In the emerging age of cancer, how can our growing understanding of the biology of ageing inform cancer biology?
This paper references
10.1038/nrc1675
Cancer and ageing: a nexus at several levels
L. Balducci (2005)
10.1016/S0140-6736(11)61720-0
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
P. Rothwell (2012)
10.1126/SCIENCE.1122446
Cellular Senescence in Aging Primates
U. Herbig (2006)
10.1016/j.cell.2007.07.003
Cellular Senescence in Cancer and Aging
M. Collado (2007)
a cohort study among people with type 2 diabetes
Libby (2009)
10.1158/0008-5472.CAN-09-3228
Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index.
Changhan Lee (2010)
10.1007/s00360-007-0237-5
Negligible senescence in the longest living rodent, the naked mole-rat: insights from a successfully aging species
R. Buffenstein (2007)
10.1111/j.1474-9726.2006.00236.x
Does caloric restriction extend life in wild mice?
J. Harper (2006)
:Dynamics of Cancer: Incidence, Inheritance, and Evolution
D. Wodarz (2009)
10.1073/pnas.0905252106
Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat
A. Seluanov (2009)
10.1186/1471-2164-12-27
A data mining approach for classifying DNA repair genes into ageing-related or non-ageing-related
A. Freitas (2010)
10.1016/j.cell.2012.12.010
Monitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model
C. Burd (2013)
10.1016/j.cell.2005.02.003
Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors
J. Campisi (2005)
10.2741/1808
Effect of host age on tumor growth rate in rodents.
V. Anisimov (2006)
10.1073/PNAS.97.15.8403
Distinct spectra of somatic mutations accumulated with age in mouse heart and small intestine.
M. Dollé (2000)
10.1158/1055-9965.EPI-07-0203
Adiposity and Age are Statistically Related to Enhanced RASSF1A Tumor Suppressor Gene Promoter Methylation in Normal Autopsy Kidney Tissue
I. Peters (2007)
analysis of the time course of risks and benefits in 51 randomised controlled trials
Rothwell (2012)
10.1093/bioinformatics/btp073
Meta-analysis of age-related gene expression profiles identifies common signatures of aging
J. P. Magalhães (2009)
10.1073/pnas.211053698
Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging
A. Krtolica (2001)
escaping horizon
Anisimov (2009)
importance of endogenous estradiol concentrations
Ho (1987)
10.1038/nrc2562
How does SIRT1 affect metabolism, senescence and cancer?
C. Brooks (2009)
10.1093/OXFORDJOURNALS.EPIREV.A000809
Height, leg length, and cancer risk: a systematic review.
D. Gunnell (2001)
senescence in cancer and aging
J. Campisi (2007)
10.1177/0193945910394380
Systematic Review
F. Nabavi (2012)
Akt signalling pathway and cancer
Fresno Vara (2004)
10.1038/ncomms1001
Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer.
D. Herranz (2010)
10.1001/JAMA.291.10.1226
Caloric restriction and incidence of breast cancer.
K. Michels (2004)
metabolic and molecular mechanisms
V. D. Longo (2010)
Cancer burden in the year
D. M. Parkin (2000)
good citizens, bad neighbors
Campisi (2005)
10.1073/PNAS.0305300101
Temporal linkage between the phenotypic and genomic responses to caloric restriction.
J. Dhahbi (2004)
10.1016/j.otohns.2009.05.016
Nature
R. Rosenfeld (2009)
10.1172/JCI31405
Immune surveillance of tumors.
J. Swann (2007)
10.1016/j.ccr.2011.12.020
Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib.
L. Li (2012)
10.1161/01.CIR.0000013836.85741.17
Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction
Tohru Minamino (2002)
10.1001/JAMA.298.17.2028
Cause-specific excess deaths associated with underweight, overweight, and obesity.
K. Flegal (2007)
Trends Pharmacol. Sci
(2010)
10.1158/0008-5472.CAN-06-3452
Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion.
Dan Liu (2007)
10.1038/nature08984
Biodemography of human ageing
J. Vaupel (2010)
10.1038/nrc1408
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
E. Calle (2004)
10.1093/gerona/gls087
Cancer and longevity--is there a trade-off? A study of cooccurrence in Danish twin pairs born 1900-1918.
K. Christensen (2012)
10.1038/nrc2962
SIRT1: recent lessons from mouse models
D. Herranz (2010)
10.1111/j.1474-9726.2009.00481.x
DNA damage response and cellular senescence in tissues of aging mice
C. Wang (2009)
10.1126/SCIENCE.7063854
Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence.
R. Weindruch (1982)
10.1079/BJN19740060
Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.
J. Durnin (1974)
Dietary intervention at middle age: caloric restriction but not dehydroepiandrosterone sulfate increases lifespan and lifetime cancer incidence in mice.
T. D. Pugh (1999)
Mutation frequency and specificity with age in liver, bladder and brain of lacI transgenic mice.
G. R. Stuart (2000)
10.1016/S0092-8674(00)80762-X
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
L. Chin (1999)
10.1016/S0092-8674(00)80580-2
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
K. Rudolph (1999)
10.1016/S1470-2045(12)70112-2
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.
A. M. Algra (2012)
10.1093/JNCI/89.20.1489
Aging and cancer: issues of basic and clinical science.
W. Ershler (1997)
10.1200/JCO.2009.27.4290
Influence of sex hormones on cancer progression.
E. Folkerd (2010)
Age-dependent induction of hepatic tumor regression by the tissue microenvironment after transplantation of neoplastically transformed rat liver epithelial cells into the liver.
K. McCullough (1997)
Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres.
S. Franco (2002)
10.1038/nature11432
Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study
J. Mattison (2012)
10.1016/J.YEXCR.2004.07.006
From cells to ageing: a review of models and mechanisms of cellular senescence and their impact on human ageing.
J. P. Magalhães (2004)
10.1089/rej.2012.1324
The role of DNA methylation in aging, rejuvenation, and age-related disease.
A. A. Johnson (2012)
10.1056/NEJMra0804615
DNA damage, aging, and cancer.
J. Hoeijmakers (2009)
10.1016/j.cell.2005.01.028
DNA Repair, Genome Stability, and Aging
D. Lombard (2005)
10.1016/j.tree.2011.01.002
Peto's Paradox: evolution's prescription for cancer prevention.
Aleah F. Caulin (2011)
10.1371/journal.pone.0000876
Intra-Organ Variation in Age-Related Mutation Accumulation in the Mouse
R. Busuttil (2007)
10.1016/S0749-0690(18)30182-4
Cancer of the oldest old. What we have learned from autopsy studies.
G. Stanta (1997)
10.1038/NG1297-431
Rapid accumulation of genome rearrangements in liver but not in brain of old mice
M. Dollé (1997)
10.1371/journal.pone.0006654
Timed Somatic Deletion of p53 in Mice Reveals Age-Associated Differences in Tumor Progression
G. Hinkal (2009)
10.1016/S0889-8529(18)30455-9
Insulin-like growth factors and aging.
M. Hammerman (1987)
10.1038/35077256
Cancer epidemiology in the last century and the next decade
J. Peto (2001)
10.1038/ncb2643
Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan
D. Baker (2013)
10.1126/science.1173635
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
R. Colman (2009)
10.1210/EN.2003-0374
Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span.
K. Coschigano (2003)
10.1016/J.CTRV.2003.07.007
PI3K/Akt signalling pathway and cancer.
J. A. Fresno Vara (2004)
10.1111/j.1474-9726.2011.00718.x
Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination
Nuno M V Gomes (2011)
10.1353/jod.2004.0022
Christianity and Democracy: The Global Picture
P. Berger (2004)
10.1111/j.1474-9726.2010.00588.x
Resistance to experimental tumorigenesis in cells of a long‐lived mammal, the naked mole‐rat (Heterocephalus glaber)
S. Liang (2010)
correlation to extended longevity
Y. Ikeno (2003)
10.1002/EJI.1830230950
Increased cytokine production in mononuclear cells of healthy elderly people
U. Fagiolo (1993)
10.1038/nature05949
Delayed ageing through damage protection by the Arf/p53 pathway
A. Matheu (2007)
10.1093/JNCI/72.1.161
B16 murine melanoma and aging: slower growth and longer survival in old mice.
W. Ershler (1984)
10.1016/j.cell.2011.11.019
Aging
(2011)
a nexus at several levels
L. Balducci (2005)
powerful targets for drug discovery
J. P. de Magalhaes (2012)
10.1111/j.1474-9726.2011.00702.x
Fat maintenance is a predictor of the murine lifespan response to dietary restriction
Chen-Yu Liao (2011)
10.1111/j.1474-9726.2008.00431.x
Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan
A. Seluanov (2008)
10.1002/cncr.10593
Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden
B. Edwards (2002)
10.1093/JNCI/86.17.1303
Altered angiogenesis underlying age-dependent changes in tumor growth.
R. Pili (1994)
10.1056/NEJMp1113569
The burden of disease and the changing task of medicine.
D. Jones (2012)
10.1126/SCIENCE.273.5271.70
The Aging Immune System: Primer and Prospectus
R. Miller (1996)
10.1158/0008-5472.CAN-07-2924
Circulating levels of inflammatory cytokines and risk of colorectal adenomas.
S. Kim (2008)
Acute myelogenous leukemia and aging
J. E. Lancet (2000)
10.1038/nature05092
p16INK4a induces an age-dependent decline in islet regenerative potential
J. Krishnamurthy (2006)
Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.
S. Dunn (1997)
10.1371/journal.pone.0009188
A Human-Like Senescence-Associated Secretory Phenotype Is Conserved in Mouse Cells Dependent on Physiological Oxygen
Jean-Philippe Coppé (2010)
Population-based study からみた神経予後不良因子の検討
鮫島 浩 (2009)
10.1016/0092-8674(93)90586-F
Cell
AC Tose (1993)
10.1093/gerona/glp017
Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice.
Y. Ikeno (2009)
10.1038/nature07205
Cancer-related inflammation
A. Mantovani (2008)
epidemiological evidence and proposed mechanisms
E. E. Calle (2004)
10.1038/onc.2008.436
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
E. Lara (2009)
10.1016/j.mad.2008.02.004
Carcinogenesis and aging 20 years after: Escaping horizon
V. Anisimov (2009)
10.1038/nature10600
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
D. Baker (2011)
10.1007/s11357-011-9361-y
Accelerated protein evolution analysis reveals genes and pathways associated with the evolution of mammalian longevity
Y. Li (2011)
10.1124/pr.110.004499
Genome-Environment Interactions That Modulate Aging: Powerful Targets for Drug Discovery
J. de Magalhães (2012)
[INTRODUCTION TO GERONTOLOGY].
J. P. Maschi (1964)
10.18632/AGING.100114
Fasting and cancer treatment in humans: A case series report
Fernando M. Safdie (2009)
10.1016/J.YGYNO.2004.12.026
The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study.
H. Maas (2005)
10.1093/GERONJ/44.6.63
The importance of immunesenescence in the incidence and malignant properties of cancer in hosts of advanced age.
P. Kaesberg (1989)
10.1038/nature08221
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
D. Harrison (2009)
10.1038/NM1097-1141
Growth hormone treatment induces mammary gland hyperplasia in aging primates
Siu T. Ng (1997)
10.2353/AJPATH.2007.070298
Atherosclerosis and vascular aging as modifiers of tumor progression, angiogenesis, and responsiveness to therapy.
H. Klement (2007)
10.1038/ng.2270
Detectable clonal mosaicism and its relationship to aging and cancer
K. Jacobs (2012)
10.1210/JCEM-64-1-51
Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations.
K. Ho (1987)
10.1093/GERONA/58.4.B291
Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity.
Y. Ikeno (2003)
J. Clin. Endocrinol. Metab
(1987)
10.1038/nature05985
The common biology of cancer and ageing
T. Finkel (2007)
10.1002/ijc.22351
The effects of aging on tumor growth and angiogenesis are tumor‐cell dependent
M. Reed (2007)
10.1093/nar/gks1155
Human Ageing Genomic Resources: Integrated databases and tools for the biology and genetics of ageing
Robi Tacutu (2013)
10.1139/Z99-015
Age and growth estimates of bowhead whales (Balaena mysticetus) via aspartic acid racemization
J. George (1999)
10.1136/bmj.315.7115.1030
There is no such thing as aging
R. Peto (1997)
10.1073/pnas.1217211109
Cancer resistance in the blind mole rat is mediated by concerted necrotic cell death mechanism
V. Gorbunova (2012)
10.1038/bjc.1975.242
Cancer and ageing in mice and men.
R. Peto (1975)
10.1016/S0959-8049(01)00267-2
Cancer burden in the year 2000. The global picture.
D. Parkin (2001)
10.1016/S0047-6374(02)00028-3
Large genome rearrangements as a primary cause of aging
J. Vijg (2002)
10.1093/carcin/bgp127
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.
F. Colotta (2009)
10.1016/S0047-6374(03)00027-7
Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes
M. Pedersen (2003)
10.1038/nature08980
The genetics of ageing
C. Kenyon (2010)
10.1126/SAGEKE.2006.10.NF16
The age of cancer.
M. Leslie (2006)
recent lessons from mouse models
D. Herranz (2010)
10.2337/dc08-2175
New Users of Metformin Are at Low Risk of Incident Cancer
G. Libby (2009)
10.1002/PROS.10204
Cellular senescence in the pathogenesis of benign prostatic hyperplasia
P. Castro (2003)
primer and prospectus
Miller (1996)
10.1038/nature05091
Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing
A. Molofsky (2006)
10.1093/GERONA/60.11.1369
The naked mole-rat: a new long-living model for human aging research.
R. Buffenstein (2005)
10.18632/AGING.100498
Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
E. Komarova (2012)
10.1016/j.mad.2006.11.016
Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans
C. Franceschi (2007)
10.1146/ANNUREV.MED.54.101601.152156
Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans.
S. Hursting (2003)
10.1038/ng.2271
Detectable clonal mosaicism from birth to old age and its relationship to cancer
C. Laurie (2012)
10.1016/j.mrrev.2011.05.001
A review and appraisal of the DNA damage theory of ageing.
A. Freitas (2011)
links to genetic instability
F. Colotta (2009)
10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J
Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis
A. Grimberg (2000)
A case series report
Safdie (2009)
10.1158/0008-5472.CAN-06-1500
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.
M. Zakikhani (2006)
10.1126/scitranslmed.3001845
Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans
J. Guevara-Aguirre (2011)
10.1002/bies.20760
Cell divisions and mammalian aging: integrative biology insights from genes that regulate longevity
J. de Magalhães (2008)
10.1016/j.tips.2009.11.004
Calorie restriction and cancer prevention: metabolic and molecular mechanisms.
V. Longo (2010)
10.1371/journal.pone.0002020
The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth
R. Firestein (2008)
10.1016/j.mad.2008.02.014
Modification of the ATM/ATR directed DNA damage response state with aging and long after hepatocyte senescence induction in vivo
S. Panda (2008)
10.1007/BF00398189
Effect of age on dose-response relationship in carcinogenesis induced by single administration of N-nitrosomethylurea in female rats
V. Anisimov (2004)
10.1016/j.cmet.2010.03.014
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.
Adem Kalender (2010)
10.2337/db06-1656
Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans
L. Fontana (2007)
10.1111/j.1474-9726.2008.00414.x
Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice
R. Strong (2008)
10.1016/j.molcel.2008.09.011
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.
R. Wang (2008)
10.1093/GERONJ/46.5.B180
Influence of age and long-term dietary restriction on plasma insulin-like growth factor-1 (IGF-1), IGF-1 gene expression, and IGF-1 binding proteins.
C. Breese (1991)
The influence of age and comorbidity on treatment and prognosis of ovarian cancer : a population - based study
R. F. Kruitwagen (2000)
10.1186/1741-7015-9-33
Understanding the benefit of metformin use in cancer treatment
Ryan J O Dowling (2011)
10.1016/S0889-8588(05)70287-2
Acute myelogenous leukemia and aging. Clinical interactions.
J. Lancet (2000)
10.1016/S1040-8428(02)00121-X
The relationship between aging and carcinogenesis: a critical appraisal.
V. Anisimov (2003)
From cells to ageing: a review of models and mechanisms of cellular senescence and their impact on human ageing.
J. de Magalhães (2004)
10.1056/NEJM198608283150906
The relation between survival and age at diagnosis in breast cancer.
H. Adami (1986)
10.1093/nar/gkm756
Changes in DNA repair during aging
V. Gorbunova (2007)
Excess of rare cancers in Werner syndrome (adult progeria).
M. Goto (1996)



This paper is referenced by
10.1186/s12979-018-0117-8
Immune-inflammatory responses in the elderly: an update
G. Accardi (2018)
Associations of Anxiety and Psychological Distress with Cancer in US Adults: Results from the 2012 National Health Interview Survey
K. Wang (2014)
10.3389/fimmu.2014.00360
Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape?
Valentin S Bruttel (2014)
10.1016/j.mad.2017.07.001
Stress, cell senescence and organismal ageing
J. P. Magalhães (2018)
10.1016/j.exger.2018.02.004
Withanolide A extends the lifespan in human EGFR-driven cancerous Caenorhabditis elegans
B. A. Akhoon (2018)
10.1016/j.dsx.2020.05.013
Diabetes and metabolic syndrome as risk factors for COVID-19
M. Marhl (2020)
10.1101/743781
A Multidimensional Systems Biology Analysis of Cellular Senescence in Ageing and Disease
Roberto A. Avelar (2019)
10.1109/ICICT48043.2020.9112464
Comparative Analysis to Predict Breast Cancer using Machine Learning Algorithms: A Survey
Tanishk Thomas (2020)
10.1038/srep32566
Discover the network mechanisms underlying the connections between aging and age-related diseases
J. Yang (2016)
10.1007/978-3-030-52663-4
Explaining Health Across the Sciences
S. Rattan (2020)
10.18632/oncotarget.27344
Aging and cancer: Is glucose a mediator between them?
A. G. Golubev (2019)
10.18632/aging.101305
Identification of polymorphisms in cancer patients that differentially affect survival with age
Aoife Doherty (2017)
10.2492/INFLAMMREGEN.35.106
Cellular senescence and liver cancer: a gut microbial connection
S. Yoshimoto (2015)
Age and Gender Differences in the Association between Serious Psychological Distress and Cancer: Findings from the 2003, 2005, and 2007 Health Information National Trends Surveys (HINTS)
Kesheng Wang (2014)
10.1007/s00384-020-03644-5
Trends in incidence, mortality rates, and survival of colorectal cancer in Western Australia from 1990 to 2014: a retrospective whole-population longitudinal study
Suresh Karuppannan (2020)
10.1080/09553002.2018.1562252
Low-dose radiobiology program at Canadian nuclear laboratories: past, present, and future
Y. Wang (2018)
10.1093/mutage/geu002
Impact of a complex nutraceutical supplement on primary tumour formation and metastasis in Trp53+/- cancer-prone mice.
V. Aksenov (2014)
10.1128/MCB.00359-18
Senescent Breast Luminal Cells Promote Carcinogenesis through Interleukin-8-Dependent Activation of Stromal Fibroblasts
H. Al-Khalaf (2018)
10.1016/j.mad.2017.10.003
Increased age-adjusted hazard of death associated with a common single nucleotide polymorphism of the human RAD52 gene in a cardiovascular cohort
P. Lénárt (2017)
10.1016/j.smim.2018.09.001
NLRP3 inflammasome activation in inflammaging.
E. Latz (2018)
10.1007/978-3-662-46410-6_1
Cancer Immunotherapy Confers a Global Benefit
Z. Aryan (2015)
10.1101/2020.08.25.266403
An Integrative Analysis of the Age-Associated Genomic, Transcriptomic and Epigenetic Landscape across Cancers
Kasit Chatsirisupachai (2020)
Impact of a complex nutraceutical supplement on primary tumour formation and metastasis in Trp53 +/- cancer-prone mice
C. David (2014)
10.1109/TCBB.2014.2355218
Predicting the Pro-Longevity or Anti-Longevity Effect of Model Organism Genes with New Hierarchical Feature Selection Methods
C. Wan (2015)
10.1101/377226
Cancer evolution in a changing microenvironment
Xiaowei Jiang (2018)
Ageing and Cancer: A complex relationship
E. Moloney (2014)
10.18632/oncotarget.8795
Type I collagen aging impairs discoidin domain receptor 2-mediated tumor cell growth suppression
C. Saby (2016)
Genomic instability as a link between cancer and aging
Rubén Sebastián Pérez (2016)
Epidemiological data of 1418 Cancer Cases of Inpatient in Al-Sadder Teaching Hospital, Misan Province from 2011-2018 (Surveillance Study)
Khalid Obiad Mohsin Almohammadawi (2018)
10.1038/srep17660
Quantifying replicative senescence as a tumor suppressor pathway and a target for cancer therapy
Ignacio A Rodriguez-Brenes (2015)
10.1016/j.phrs.2019.03.018
Dysregulation of the Hippo pathway signaling in aging and cancer
Yiu To Yeung (2019)
10.1080/19336918.2018.1472182
Age-related modifications of type I collagen impair DDR1-induced apoptosis in non-invasive breast carcinoma cells
C. Saby (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar